Skip to content
10-Q

Quarterly Report

US-China Biomedical Technology, Inc.

0001683168-18-003080

← back to feed
Filed
Oct 16, 2018 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2019 · Oct 10, 2018 15.51M sh
Operating Cash Flow Q2 2019 · Aug 31, 2018 −$241.04K
Operating Cash Flow Q2 2019 · Aug 31, 2017 −$166.31K
Stockholders Equity Q2 2019 · Aug 31, 2018 $294.74K
Stockholders Equity Q2 2019 · Feb 28, 2018 −$271.81K
Total Liabilities Q2 2019 · Aug 31, 2018 $77.52K
Total Liabilities Q2 2019 · Feb 28, 2018 $352.43K
Current Assets Q2 2019 · Aug 31, 2018 $353.03K
Current Assets Q2 2019 · Feb 28, 2018 $61.41K
Total Assets Q2 2019 · Aug 31, 2018 $372.25K
Total Assets Q2 2019 · Feb 28, 2018 $80.63K
Sga Expense Q2 2019 · Aug 31, 2018 $142.97K
Sga Expense Q2 2019 · Aug 31, 2018 $229.56K
Sga Expense Q2 2019 · Aug 31, 2017 $229.88K
Sga Expense Q2 2019 · Aug 31, 2017 $269.92K
Net Income Q2 2019 · Aug 31, 2018 −$142.97K
Net Income Q2 2019 · Aug 31, 2018 −$417.61K
Net Income Q2 2019 · Aug 31, 2017 −$234.88K
Net Income Q2 2019 · Aug 31, 2017 −$274.92K
Operating Income Q2 2019 · Aug 31, 2018 −$142.97K
Operating Income Q2 2019 · Aug 31, 2018 −$229.56K
Operating Income Q2 2019 · Aug 31, 2017 −$229.88K
Operating Income Q2 2019 · Aug 31, 2017 −$269.92K